Helios CORP Announces New Product at Two Prestigious Health and Wellness Trade Shows

Share Article

Helios CORP successfully showcased EstroG-100®, a highly-anticipated, natural menopause relief product after the completion of its third human clinical trial

News Image
Manufacturers were very interested in what our product does. This validates to us that having this clinical study changed the industry’s perceptions and thoughts about what EstroG-100 has to offer patients.

Helios CORP recently debuted their new botanical supplement, EstroG-100®, at two different, yet equally prestigious health and wellness conferences, having recently completed their third successful human clinical study six weeks ago. The product, which is designed to alleviate symptoms of menopause, has been in development for over a decade, but is just now gaining recognition in the medical industry following the completion of its most recent clinical trial.

Helios CORP presented their new product to both doctors and manufacturers on Oct. 8 and 9 at Supply Side West (SSW), the world's largest annual nutritional ingredients trade show, which boasts 1,300 booths and hosts nearly 25,000-30,000 attendees. In addition to communicating the efficacy and safety of EstroG-100®, Helios CORP also discussed the third study with some of the largest Pharma companies in the world.

"Manufacturers were very interested in what our product does. This validates to us that having this clinical study changed the industry’s perceptions and thoughts about what EstroG-100 has to offer patients," said Michael Jeffers, President of Helios CORP. Jeffers firmly believes the market is in need of a safe, effective product that balances both science and performance. "We're committed to this category because 13.2% of the U.S. population are women in menopause (45M women), and there are thousands of women who are entering into this phase daily. The choices in menopause treatments over the last 12 years have been very poor."

Additionally, Helios CORP presented EstroG-100 at the North American Menopause Society (NAMS) conference, which is the world's single largest menopause trade association. In its 25th year, the conference is held annually and took place from Oct. 15 through Oct. 17 of this year. This is the first NAMS conference Helios CORP has attended.

"We felt that after the third clinical study, we’d make a commitment to present our latest technology to doctors, nurses, consumers, and midwives that attend this event," Jeffers states. The conference gave Helios CORP the opportunity to speak directly with doctors in order to discuss their opinions on what is most important when treating symptoms of menopause. Jeffers considers attendance at NAMS a success. "Feedback was 100% positive and very supportive. All are excited about the technology and the prospect of using this natural ingredient that works in as few as 7-14 days, along with managing multiple symptoms."

EstroG-100 is a non-hormonal and non-estrogenic, 100% natural botanical supplement that has been reviewed by the FDA and currently holds a Nutritional Dietary Ingredient classification, both of which validate the product is safe and effective.

About Helios CORP
Helios CORP is a nutritional company that relies on technology and research to develop even better performance ingredients. EstroG-100, Omega Clear, and Transport-C Plus are their three main products. To learn more, visit helioscorp.net.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Michael Jeffers, President
HeliosCORP
+1 (888) 511-1142
Email >